← Back
$RPRX All transactions

Royalty Pharma plc

▼ SELL 10b5-1 Plan

$ Value

$1.5M

Shares

32,916

Price

$46

Filed

Mar 25

Insider

Name

Coyne Terrance P.

Title

EVP & CFO

CIK

0001814876

Roles

Officer

Transaction Details

Transaction Date

2026-03-23

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

65,832

Footnotes

All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 8, 2025. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.30 to $45.94 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0001814876-26-000014

Form Type

4

Issuer CIK

0001802768

Coyne Terrance P.'s History

Date Ticker Type Value
2026-04-01 RPRX $91K
2026-04-01 RPRX $1.6M
2026-03-23 RPRX $1.5M
2026-03-23 RPRX $85K
2025-08-08 RPRX G $0
2025-08-06 RPRX A $0
2025-05-16 RPRX A $0
2025-05-08 RPRX A $0

Other Insiders at RPRX (90d)

Insider Bought Sold Last
Bassler Bonnie L 2026-03-31
Coyne Terrance P.
EVP & CFO
$1.8M 2026-04-01